Home › Malattia di Crohn › Pennsylvania › Philadelphia
Studi clinici su Malattia di Crohn a Philadelphia, PA
13 studi su Malattia di Crohn cercano partecipanti presso sedi a Philadelphia e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
In reclutamentoFase 3
- Thomas Jefferson University Hospital ( Site 5133), Philadelphia
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
In reclutamentoFase 2
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- Children's Hospital of Philadelphia, Philadelphia
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 2/3
- University of Pennsylvania, Philadelphia
- Jefferson Digestive Health Institute, Philadelphia
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
In reclutamentoFase 3
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
In reclutamentoFase 3
- Children's Hospital of Philadelphia (CHOP), Philadelphia
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
In reclutamentoFase 3
- Children's Hospital of Philadelphia, Philadelphia
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- Children's Hospital of Philadelphia - Main /ID# 262197, Philadelphia
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
In reclutamentoFase 4
- Children's Hospital of Philadelphia, Philadelphia
Precise Infliximab Exposure and Pharmacodynamic Control
In reclutamentoFase 2/3
- Nemours Children's Health System-Wilmington, Wilmington · a 25 mi di distanza
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
In reclutamento
- Children's Hospital of Philadelphia, Philadelphia
Studi su Malattia di Crohn in altre città
- New York City, NY35 studi
- Boston, MA19 studi
- Miami, FL19 studi
- Cleveland, OH19 studi
- St. Louis, MO19 studi
- Tyler, TX17 studi
- Houston, TX17 studi
- Orlando, FL17 studi
- Atlanta, GA17 studi
- San Antonio, TX15 studi
- San Diego, CA15 studi
- Los Angeles, CA15 studi
Altri studi a Philadelphia
- Cancro (tutti i tipi)59 studi
- Cancro al seno56 studi
- Cancro del polmone non a piccole cellule51 studi
- Cancro metastatico46 studi
- Cancro alla prostata44 studi
- Cancro colorettale44 studi
- Cancro ovarico44 studi
- Cancro ai polmoni36 studi
- Leucemia mieloide acuta34 studi
- Insufficienza cardiaca31 studi
- Cancro dell'endometrio28 studi
- Depressione26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.